Harvard Bioscience, Inc. (HBIO)Â
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
HBIO Insider Trading Activity
HBIO Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $90,500 | 2 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Green James W | Chief Executive Officer | 2 | $90,500 | 0 | $0 | $90,500 |
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.
Insider Activity of Harvard Bioscience, Inc.
Over the last 12 months, insiders at Harvard Bioscience, Inc. have bought $90,500 and sold $0 worth of Harvard Bioscience, Inc. stock.
On average, over the past 5 years, insiders at Harvard Bioscience, Inc. have bought $222,280 and sold $582,106 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Green James W (Chief Executive Officer) — $90,500.
The last purchase of 10,000 shares for transaction amount of $29,100 was made by Green James W (Chief Executive Officer) on 2024‑06‑13.
List of Insider Buy and Sell Transactions, Harvard Bioscience, Inc.
| 2024-06-13 | Green James W | Chief Executive Officer | 10,000 0.0242% | $2.91 | $29,100 | -18.56% | ||
| 2024-06-06 | Green James W | Chief Executive Officer | 20,000 0.0474% | $3.07 | $61,400 | -19.80% | ||
| 2023-08-17 | Green James W | Chief Executive Officer | 25,000 0.06% | $4.38 | $109,500 | -2.08% | ||
| 2023-03-15 | Green James W | Chief Executive Officer | 20,000 0.0468% | $2.60 | $52,000 | +71.21% | ||
| 2023-03-15 | EDRICK ALAN I | director | 16,192 0.0382% | $2.62 | $42,423 | +71.21% | ||
| 2023-03-14 | Green James W | Chief Executive Officer | 20,000 0.0475% | $2.67 | $53,400 | +69.29% | ||
| 2023-03-14 | EDRICK ALAN I | director | 13,808 0.0328% | $2.67 | $36,867 | +69.29% | ||
| 2022-12-01 | Green James W | Chief Executive Officer | 15,000 0.0341% | $2.61 | $39,150 | +54.15% | ||
| 2022-11-30 | Green James W | Chief Executive Officer | 15,000 0.0341% | $2.41 | $36,150 | +66.41% | ||
| 2022-08-26 | LOY BERTRAND | 9,291 0.0231% | $3.41 | $31,682 | -5.78% | |||
| 2022-08-24 | LOY BERTRAND | 8,244 0.0207% | $3.34 | $27,535 | -2.82% | |||
| 2022-08-22 | LOY BERTRAND | 4,918 0.0118% | $3.16 | $15,541 | -2.21% | |||
| 2022-08-18 | LOY BERTRAND | 1,151 0.0028% | $3.19 | $3,672 | -2.52% | |||
| 2022-08-17 | Green James W | Chief Executive Officer | 40,000 0.0961% | $3.19 | $127,600 | -2.82% | ||
| 2022-06-15 | Green James W | Chief Executive Officer | 30,000 0.0734% | $3.71 | $111,300 | -15.53% | ||
| 2022-05-06 | Green James W | Chief Executive Officer | 10,000 0.0219% | $3.40 | $34,000 | -17.55% | ||
| 2021-08-23 | Sale | Green James W | Chief Executive Officer | 48,175 0.1175% | $8.02 | $386,364 | -26.02% | |
| 2021-05-21 | Sale | Green James W | Chief Executive Officer | 24,312 0.0605% | $7.14 | $173,588 | -2.52% | |
| 2021-05-20 | Sale | Green James W | Chief Executive Officer | 14,876 0.0372% | $7.03 | $104,578 | -0.43% | |
| 2021-05-18 | Sale | Green James W | Chief Executive Officer | 39,188 0.0988% | $7.41 | $290,383 | -4.37% |
Insider Historical Profitability
| Green James W | Chief Executive Officer | 3111091 7.0587% | $1.87M | 16 | 5 | +22.76% |
| Skystone Advisors LLC | 10 percent owner | 3744819 8.4966% | $2.25M | 64 | 5 | +9.98% |
| GRAZIANO CHANE | 10 percent owner | 3105150 7.0452% | $1.86M | 5 | 0 | +21.41% |
| HSO LIMITED PARTNERSHIP | 10 percent owner | 2757257 6.2559% | $1.65M | 40 | 2 | +8.24% |
| GREEN DAVID | director | 925571 2.1% | $555,435.16 | 15 | 73 | +46.82% |
| Duchemin Jeffrey | Chief Executive Officer | 830888 1.8852% | $498,615.89 | 4 | 12 | +3.29% |
| LEWIS EARL R | director | 467350 1.0604% | $280,456.74 | 9 | 1 | +28.78% |
| LOY BERTRAND | 399651 0.9068% | $239,830.57 | 11 | 0 | +3.36% | |
| Gagnon Robert E. | Chief Financial Officer | 321169 0.7287% | $192,733.52 | 6 | 12 | +16.32% |
| EDRICK ALAN I | director | 202485 0.4594% | $121,511.25 | 3 | 0 | +66.06% |
| KENNEDY JOHN F | director | 177330 0.4023% | $106,415.73 | 2 | 0 | <0.0001% |
| UVEGES GEORGE | director | 142685 0.3237% | $85,625.27 | 5 | 2 | +13.68% |
| Eade Katherine A. | director | 121515 0.2757% | $72,921.15 | 1 | 0 | +15.32% |
| Loewald Thomas W | director | 103200 0.2341% | $61,930.32 | 1 | 0 | +15.6% |
| HARTE NEAL J | director | 25258 0.0573% | $15,157.33 | 0 | 1 |
HBIO Institutional Investors: Active Positions
| Increased Positions | 51 | +52.58% | 2M | +5.26% |
| Decreased Positions | 38 | -39.18% | 2M | -5.84% |
| New Positions | 16 | New | 376,540 | New |
| Sold Out Positions | 14 | Sold Out | 418,446 | Sold Out |
| Total Postitions | 110 | +13.4% | 31M | -0.58% |
HBIO Ownership Change vs Market
Institutional Investor Ownership
| Blackrock, Inc. | $1,896.00 | 6.78% | 2.98M | +65,235 | +2.24% | 2024-12-31 |
| Punch & Associates Investment Management, Inc. | $1,753.00 | 6.26% | 2.76M | -17,100 | -0.62% | 2024-12-31 |
| Harvey Partners, Llc | $1,706.00 | 6.1% | 2.68M | -32,000 | -1.18% | 2024-12-31 |
| Amh Equity Ltd | $1,590.00 | 5.68% | 2.5M | +111,132 | +4.65% | 2024-12-31 |
| Vanguard Group Inc | $1,372.00 | 4.9% | 2.16M | +3,803 | +0.18% | 2024-12-31 |
| Royce & Associates Lp | $1,250.00 | 4.47% | 1.97M | +513,664 | +35.39% | 2024-12-31 |
| Dimensional Fund Advisors Lp | $1,059.00 | 3.78% | 1.67M | -50,766 | -2.96% | 2024-12-31 |
| Granahan Investment Management, Llc | $1,029.00 | 3.68% | 1.62M | -248,251 | -13.31% | 2024-12-31 |
| 272 Capital Lp | $859.00 | 3.07% | 1.35M | -184,423 | -12.01% | 2024-12-31 |
| Heartland Advisors Inc | $763.00 | 2.73% | 1.2M | 0 | 0% | 2024-12-31 |